COMMUNIQUÉS West-GlobeNewswire

Virbac : bilan semestriel contrat de liquidité au 30 juin 2017

25/07/2017 - 11:42

Carros, le 5 juillet 2017 BILAN SEMESTRIEL DES MOYENS ALLOUES AU CONTRAT DE LIQUIDITE Au titre du contrat de liquidité confié par la société VIRBAC S.A. à la société EXANE BNP PARIBAS, les moyens suivants figuraient au [...]

Affimed Announces Second Quarter 2017 Financial Results and Corporate Update Conference Call

25/07/2017 - 11:00

Heidelberg, Germany, July 25, 2017 - Affimed N.V. (Nasdaq: AFMD) today announced that on August 1, 2017, the Company will release its financial results for the quarter ended June 30, 2017. The Company's management team [...]

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares

25/07/2017 - 09:00

FIT Biotech Oy Company release July 25, 2017 at 10:00 AM EET Conversion of FIT Biotech Oy's Convertible Capital Notes into shares Related to Convertible Note and Warrant Programmes established on September 26, 2016 [...]

Sandoz expands partnership with World Child Cancer, to help children access treatment in four developing countries

25/07/2017 - 07:15

Expanded partnership to help "even the odds" of survival for children with cancer in the Philippines, Myanmar, Mexico and Ghana In developed countries, the survival rate for childhood cancer is 80%, while in developing [...]

Novavax Announces Positive Topline Data from Phase 2 Older Adult Trial and Provides Path Forward for RSV F Vaccine Programs

24/07/2017 - 22:05

Phase 2 data in older adults (E205) demonstrate adjuvants and 2-dose regimens significantly increase the magnitude, duration and quality of the RSV F Vaccine immune response New data demonstrate that Novavax' construct [...]

Communiqué : Point sur l'obtention des autorisations des autorités de la concurrence dans le cadre du projet de rapprochement entre Essilor et Luxottica

24/07/2017 - 18:00

Point sur l'obtention des autorisations des autorités de la concurrence dans le cadre du projet de rapprochement entre Essilor et Luxottica Version PDF du communiqué Charenton-le-Pont, France et Milan, Italie (le 24 [...]

News Release: Antitrust process update for the proposed combination between Essilor and Luxottica

24/07/2017 - 18:00

Antitrust process update for the proposed combination between Essilor and Luxottica PDF Version of the news release Charenton-le-Pont, France and Milan, Italy (July 24, 2017) - The proposed combination between Essilor ( [...]

Ossur Hf : Transactions in relation to share buyback program

24/07/2017 - 18:00

Announcement from Össur hf. No. 51/2017 Reykjavík, 24 July 2017 On 1 December 2016, Össur hf. initiated a new share buy-back program, see Company announcement no. 96/2016. The purpose of the share buyback program is to [...]

Oriola Corporation - Repurchase of own shares on 24 July 2017

24/07/2017 - 17:45

ORIOLA CORPORATION STOCK EXCHANGE RELEASE 24 JULY 2017 AT 18:45 EEST In the Nasdaq Helsinki Date 24 July 2017 Exchange transaction Buy Share trading code OKDBV Amount, shares 16.657 Average price/share, EUR 3,5601 Total [...]

Innocoll and Gurnet Point Announcement relating to the Scheme becoming Effective

24/07/2017 - 15:26

NOT FOR RELEAS E, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION FOR IMMEDIATE [...]

Corning and Gerresheimer Collaborate to Deliver New Corning Valor(TM) Glass to the Pharmaceutical Packaging Market

24/07/2017 - 14:30

Remarkable glass innovation enables enhanced quality parenteral packaging CORNING, N.Y. and DUSSELDORF, GERMANY; JULY 24, 2017 - Corning Incorporated (NYSE: GLW) and Gerresheimer AG announce that they are accelerating [...]

Minerva Neurosciences Announces Departure of Directors

24/07/2017 - 14:30

WALTHAM, Mass., July 24, 2017 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system disorders, [...]

Novo Nordisk A/S - Share repurchase programme

24/07/2017 - 11:35

Bagsværd, Denmark, 24 July 2017 - On 2 February 2017, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 ( [...]

LIDDS: Clarification regarding signed research agreement

24/07/2017 - 08:55

With reference to press release LIDDS signs research agreement with major European pharma company, published 21 July 2017 at 10:00 CET, we hereby announce that the agreement party is Ferring Pharmaceuticals. Contact [...]

DEINOVE renforce la fonction de Business Développement avec l'arrivée de Sébastien Enault

24/07/2017 - 08:30

Sébastien Enault apporte à la Société une expérience confirmée dans la mise en place de collaborations dans le domaine pharmaceutique et notamment dans celui des anti-infectieux. Montpellier, le 24 juillet 2017 (8h30 [...]

DEINOVE strengthens its Business Development activity with the arrival of Sébastien Enault

24/07/2017 - 08:30

Sébastien Enault brings to the Company a proven track record in the development of collaborations in the pharmaceutical field and, in particular, in the anti-infective field. Montpellier, 24 July 2017 (8:30am CEST) - [...]

Xbrane Biopharma AB: Spherotide granted Market Authorization in Iran

24/07/2017 - 08:00

Press release 2017-07-24 Xbranes partner Pooyesh Darou has been granted Market Authorization for sales and marketing of Spherotide 1 month formulation in Iran under the local brand name Microrelin®. "This is a major [...]

ABLYNX ANNOUNCES WARRANT EXERCISE

24/07/2017 - 07:00

REGULATED INFORMATION GHENT, Belgium, 24 July 2017 - Ablynx [Euronext Brussels: ABLX; OTC: ABYLY] today announced, in conformity with Title II of the Law of 2 May 2007 and the Royal Decree of 14 February 2008, that an [...]

VALNEVA reçoit le statut de "Fast Track" de la FDA pour son candidat vaccin contre la maladie de Lyme VLA15

24/07/2017 - 07:00

Valneva reçoit le statut de "Fast Track" de la FDA pour son candidat vaccin contre la maladie de Lyme VLA15 Lyme est la maladie infectieuse transmise par vecteur qui se développe le plus rapidement aux Etats-Unis, selon [...]